This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Centre National De La Recherche Scientifique, Eli Lilly and Company, Institut Jean Paoli & Irène Calmettes. Active years: 2025.
Company Filing History:
1 out of 5,383 
1 out of 4,508 
1 out of 32 
Years Active: 2025
Title: Florence Lhospice: Innovator in Antibody Drug Conjugates
Introduction
Florence Lhospice is a notable inventor based in Bretagne, France. She has made significant contributions to the field of cancer treatment through her innovative work on antibody drug conjugates (ADCs). Her research focuses on targeting Nectin 4 with an exatecan payload, which has the potential to improve therapeutic outcomes for cancer patients.
Latest Patents
Florence Lhospice holds 1 patent for her invention titled "Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload." This patent provides a detailed disclosure of Nectin-4 ADCs that include exatecan and outlines pharmaceutical compositions and methods for using these ADCs in cancer treatment.
Career Highlights
Throughout her career, Florence has worked with prominent organizations such as Eli Lilly and Company and Université d'Aix-Marseille. Her experience in these institutions has allowed her to develop her expertise in the field of biopharmaceuticals and cancer therapies.
Collaborations
Florence has collaborated with notable professionals in her field, including Jacobus Petrus Maria Elands and Joanna Fares. These partnerships have contributed to her research and the advancement of her innovative projects.
Conclusion
Florence Lhospice is a pioneering inventor whose work on antibody drug conjugates represents a significant advancement in cancer treatment. Her contributions continue to influence the field and offer hope for improved therapeutic strategies.